In a turbulent market environment, Vincerx Pharma, Inc. (VINC) stock has reached its 52-week low, trading at $1.3. According to InvestingPro analysis, the company maintains a healthy current ratio of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback